Literature DB >> 23792024

Ceramide metabolism in mouse tissue.

Susanne Schiffmann1, Kerstin Birod, Julia Männich, Max Eberle, Marthe-Susanna Wegner, Ruth Wanger, Daniela Hartmann, Nerea Ferreiros, Gerd Geisslinger, Sabine Grösch.   

Abstract

Ceramides with different N-acyl chains can act as second messengers in various signaling pathways. They are involved in cell processes such as apoptosis, differentiation and inflammation. Ceramide synthases (CerS) are key enzymes in the biosynthesis of ceramides and dihydroceramides. Six isoenzymes (CerS1-6) catalyze the N-acylation of the sphingoid bases, albeit with strictly acyl-Coenzyme A (CoA) chain length specificity. We analyzed the mRNA expression, the protein expression, the specific activity of the CerS, and acyl-CoA, dihydroceramide and ceramide levels in different tissues by LC-MS/MS. Our data indicate that each tissue express a distinct composition of CerS, whereby the CerS mRNA expression levels do not correlate with the respective protein expression levels in the tissues. Furthermore, we found a highly significant negative correlation between the protein expression level of CerS6 and the C16:0-acyl-CoA amounts as well as between the protein expression of CerS2 and C24:0-acyl-CoA amounts. These data indicate that in mouse tissues low substrate availability is compensated by higher CerS protein expression level and vice versa. Apart from the expression level and the specific activity of the CerS, other enzymes of the sphingolipid pathway also influence the composition of ceramides with distinct chain lengths in each cell. Acyl-CoA availability seems to be less important for ceramide composition and might be compensated for by CerS expression/activity.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (dihydro)ceramide synthase; Acyl-CoA; Acyl-Coenzyme A; Cer; CerS; Ceramide; Ceramide synthase; LC–MS/MS; Mouse tissue; dhCer; dihydroceramide; liquid chromatography coupled with tandem mass spectrometry

Mesh:

Substances:

Year:  2013        PMID: 23792024     DOI: 10.1016/j.biocel.2013.06.004

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  15 in total

1.  A rapid ceramide synthase activity using NBD-sphinganine and solid phase extraction.

Authors:  Rotem Tidhar; Kacee Sims; Eden Rosenfeld-Gur; Walter Shaw; Anthony H Futerman
Journal:  J Lipid Res       Date:  2014-11-03       Impact factor: 5.922

2.  Dietary inulin decreases circulating ceramides by suppressing neutral sphingomyelinase expression and activity in mice.

Authors:  Pan Deng; Jessie B Hoffman; Michael C Petriello; Chun-Yan Wang; Xu-Sheng Li; Maria P Kraemer; Andrew J Morris; Bernhard Hennig
Journal:  J Lipid Res       Date:  2019-10-11       Impact factor: 5.922

3.  Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.

Authors:  Max Eberle; Philipp Ebel; Christoph A Mayer; Julia Barthelmes; Nadja Tafferner; Nerea Ferreiros; Thomas Ulshöfer; Marina Henke; Christian Foerch; Anika Männer de Bazo; Sabine Grösch; Gerd Geisslinger; Klaus Willecke; Susanne Schiffmann
Journal:  Immunol Cell Biol       Date:  2015-04-02       Impact factor: 5.126

4.  Ceramide synthase 4 regulates stem cell homeostasis and hair follicle cycling.

Authors:  Franziska Peters; Susanne Vorhagen; Susanne Brodesser; Kristin Jakobshagen; Jens C Brüning; Carien M Niessen; Martin Krönke
Journal:  J Invest Dermatol       Date:  2015-02-23       Impact factor: 8.551

5.  Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.

Authors:  Joseph R Goldenberg; Andrew N Carley; Ruiping Ji; Xiaokan Zhang; Matt Fasano; P Christian Schulze; E Douglas Lewandowski
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

6.  Endurance and Resistance Training Affect High Fat Diet-Induced Increase of Ceramides, Inflammasome Expression, and Systemic Inflammation in Mice.

Authors:  Cornelia Mardare; Karsten Krüger; Gerhard Liebisch; Michael Seimetz; Aline Couturier; Robert Ringseis; Jochen Wilhelm; Norbert Weissmann; Klaus Eder; Frank-Christoph Mooren
Journal:  J Diabetes Res       Date:  2015-12-14       Impact factor: 4.011

7.  Intestinal MYC modulates obesity-related metabolic dysfunction.

Authors:  Yuhong Luo; Shoumei Yang; Xuan Wu; Shogo Takahashi; Lulu Sun; Jie Cai; Kristopher W Krausz; Xiaozhen Guo; Henrique B Dias; Oksana Gavrilova; Cen Xie; Changtao Jiang; Weiwei Liu; Frank J Gonzalez
Journal:  Nat Metab       Date:  2021-07-01

8.  Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine.

Authors:  R Brunkhorst; F Friedlaender; N Ferreirós; S Schwalm; A Koch; G Grammatikos; S Toennes; C Foerch; J Pfeilschifter; W Pfeilschifter
Journal:  Neural Plast       Date:  2015-10-28       Impact factor: 3.599

9.  Palmitoyl-ceramide accumulation with necrotic cell death in A549 cells, followed by a steep increase in sphinganine content.

Authors:  Mototeru Yamane
Journal:  Biochim Open       Date:  2015-06-21

10.  Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic stroke.

Authors:  Sebastian Luger; Annette Schwebler; Rajkumar Vutukuri; Nerea Ferreiros Bouzas; Sandra Labocha; Yannick Schreiber; Robert Brunkhorst; Helmuth Steinmetz; Josef Pfeilschifter; Waltraud Pfeilschifter
Journal:  Ther Adv Neurol Disord       Date:  2018-04-19       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.